Big Buttons

• End Drug Shortages Act intro’d in Congress

  The legislation would expand the sources the FDA may use to declare drug shortages. read more →

• FDA tirzepatide ‘reconsideration’ period extended

  FDA agreed to extend until December 19 a final report on tirzepatide availability to the court.  read more →

• NPR hits the GLP-1 nail on the head

  A National Public Radio piece this week tackled the issue of compounded GLP-1 drugs and got the facts and nuance just right. read more →

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

More News

Upcoming Events

December 4:  PCAC meeting on adding several bulk drug substances to the 503A Bulks List (2 of 2)

December 5: APC CE webinar: Compounding in Special Populations

December 5: CompoundED UpDATE Regional Meeting, Scottsdale, AZ

December 13: APC Board of Directors Meeting, Las Vegas

December 13-15: A4M Longevity Fest, Las Vegas

March 14–16, 2025: APC Owner Summit, Destin, FL

The Latest Resources for Compounders

• Best Practices for Compounding Shortage Drugs
• NEW! Best Practices for Marketing Compounded Medications
• Best Practices for Compounding Ketamine
• Best Practices for Clinic Direct Billing (Office Pay)
• Statement on Peptide Compounding
• Statement on Constructive Transfer

Click here for more resources for compounding professionals

APC In the News

Legit or not? ABC News looks at the difference:

ABC News turned to APC for insight into the difference between legit GLP-1 compounders and fly-by-night 'wellness' sites.

Covering the GLP-1 shortage:

Reuters did an excellent job updating the status of the Wegovy shortage.

NPR hits the GLP-1 nail on the head:

National Public Radio did a spot-on job explaining the current situation with compounded GLP-1 drugs.

Not holding back:

We pull no punches in this article about Novo's latest shenanigans

Video appearance: APC talks the legal issues:

APC CEO Scott Brunner was a guest on "On The Pen" — a YouTube channel dedicated to all things GLP-1.

PharmExec features APC execs talking about the compounding process:

From the manufacturing process to patient and provider challenges, this PharmExec video interview covers all things compounding.

APC calls out Novo in Reuters:

Reuters used our comment that there's a difference between making molecules and compounding with them.

CBS quotes APC on resolving shortages:

Taking a different angle, this article looked how the FDA decides when to resolve a shortage.

Click here for more examples of APC in the news

Support Compounding

Our Patrons